Navigation Links
AMO Vitrax (sodium hyaluronate) viscoelastic solution

ProductsAMO Vitrax (sodium hyaluronate) viscoelastic solution
Company Advanced Medical Optics, Inc.
Item AMO Vitrax (sodium hyaluronate) viscoelastic solution
Features 
  • Provides viscosity and adhesiveness designed for small-incision surgery
  • Maintains anterior chamber depth for sate, ample working room
  • Ensures optimal protection of endothelial cells
  • Requires no refrigeration
  • Compares favorably with other adhesive viscoelastics
  • Description AMO Vitrax features a low molecular weight that assures the maximum protection and viscosity you need to achieve optimal results during phaco and small-incision surgery. The sustained viscoelastic protection also maintains anterior chamber depth for safe, ample working room and ensures maximum protection of endothelial cells.
    Info Advanced Medical Optics, Inc.
    Customer Service: (714) 247-8200

    Related medicine products :

    1. Vitrax
    2. CoEase (1.2% sodium hyaluronate) viscoelastic solution
    3. Boston Simplus Multi-Action solution
    4. Model 430 Visible Spectrophotometer High Resolution
    5. PrimeSuite Integrated Practice Management, Electronic Medical Record (EMR) and Managed Care solutions
    6. High Resolution Minioptic Endoscope
    7. High Resolution Minioptic Laparoscopes
    8. Agarose 3:1 HRB™ - High Resolution Blend
    9. Agarose, high resolution, Molecular Biology Grade
    10. Agarose, ultra high resolution, Molecular Biology Grade
    11. Agarose, Fine Resolution
    Sphincter of Oddi Solid State Catheter Adapter Cable for Polygraf ID...
    ... a unipolar lead intended for use with an ... needle design for easier use with laparoscopic procedures. ... length of 1 cm. The 4351 lead connects ... 35 cm length. Two leads are used in ...
    ... ability of the visual system to ... are,some pathological conditions that reduce contrast ... test will help in the identification ... and reduced visual acuity often occur ...
    ...
    Medicine Products:
    (Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
    (Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
    (Date:6/24/2016)... ... 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out of ... verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... throw rocks at my other children and say he was going to kill them. ...
    (Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda ... orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including ... accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. ...
    (Date:6/24/2016)... , ... June 24, 2016 , ... People across the ... Genome magazine’s Code Talker Award, an essay contest in which patients and their families ... to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education ...
    Breaking Medicine News(10 mins):
    (Date:6/24/2016)... , June 24, 2016 VolitionRx ... of Dr. Edward Futcher to the ... effective June 23, 2016.Dr. Futcher was also appointed ... Governance Committees.  As a non-executive member of the ... and strategic counsel to VolitionRx in connection with ...
    (Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
    (Date:6/23/2016)... June 23, 2016 Research and Markets ... Issue 52" report to their offering. ... treatment creates a favourable commercial environment for MedImmune to enter. ... base that will serve to drive considerable growth for effective ... serve to cap sales considerably, but development is still in ...
    Breaking Medicine Technology: